Abstract:Twenty-five chalcone derivatives containing quinazolinone were designed and synthesized. The results of antiviral biological experiments showed that (E)-3-(4-chlorophenyl)-6-fluoro-2-((2-(4-(3-(4-methoxyphenyl)acryloyl)phenoxy)ethyl)-thio)quinazolin-4(3H)-one (Z12) had a good inhibitory activity against tobacco mosaic virus (TMV), and the EC50 values of treatment and protection were 94.3 and 98.8 mu g/mL, respectively, which were better than those of ningamycin (NNM, 216.1 and 189.6 mu g/mL). The results of transmission electron microscope showed that Z12 broke TMV virus particles and formed rod structures of different lengths. The results of microscale thermophoresis experiment (MST) showed that the K-d value of Z12 binding to tobacco mosaic virus coat protein (TMV-CP) was (0.033 +/- 0.014) mu mol/L. The Kd value of Z12 was better than that of ningnanmycin [(0.106 +/- 0.024) mu mol/L], which indicated that Z12 had stronger binding ability to TMV-CP. The antibacterial test results showed that some compounds showed excellent activity against Xanthomonas oryzae pv. Oryzae (Xoo) and Xanthomonas axonopodis pv.Citri (Xac), among which ((E)-2-((2-(4-(3-(4-bromophenyl)acryloyl)phenoxy)ethyl)thio)-3-(4-chlorophenyl)-6-nitroquinazolin-4(3H)-one (Z25) showed the best activity against Xoo. The EC50 value of Xoo was 19.5 mu g/mL, which was better than those of bismerthiazol (77.1 mu g/mL) and thiodiazole copper (95.9 mu g/mL). The results of scanning electron microscope showed that the cell membrane of Xoo was shriveled and deformed after Z25 treatment. The experimental results showed that chalcone derivatives containing quinazolinone were potential antiviral and antibacterial drugs.

Study of the Synthesis, Antiviral Bioactivity and Interaction Mechanisms of Novel Chalcone Derivatives That Contain the 1,1-Dichloropropene Moiety

Synthesis and Antiviral Bioactivity of Novel Chalcone Derivatives Containing Purine Moiety

New Chalcone Derivatives: Synthesis, Antiviral Activity and Mechanism of Action

Design, Synthesis and Antiviral Activities of Chalcone Derivatives Containing Pyrimidine

New chalcone derivatives containing morpholine-thiadiazole: Design, synthesis and evaluation of against tobacco mosaic virus

Chalcone derivatives containing 1,2,4-triazole and pyridine moiety: design, synthesis, and antiviral activity

Novel chalcone derivatives containing a 1,2,4-triazine moiety: design, synthesis, antibacterial and antiviral activities

Synthesis, Biological Activity and Action Mechanism Study of Novel Chalcone Derivatives Containing Malonate.

Synthesis, Antiviral Activity, and 3D-QSAR Study of Novel Chalcone Derivatives Containing Malonate and Pyridine Moieties

Antiviral activity evaluation and action mechanism of chalcone derivatives containing phenoxypyridine

Antiviral Properties and Interaction of Novel Chalcone Derivatives Containing a Purine and Benzenesulfonamide Moiety.

Design, Synthesis, and Bioactivity of Chalcone Derivatives Containing Indanone

Synthesis and Biological Activities of Novel Chalcone Derivatives Containing Pyrazole Oxime Ethers.

Design, Synthesis and Bioactivity of Chalcone Derivative Containing Quinazolinone

Synthesis and Antiviral Evaluation of Novel 1,3,4-Oxadiazole/thiadiazole-chalcone Conjugates

Biological Activity Evaluation and Action Mechanism of Chalcone Derivatives Containing Thiophene Sulfonate.

Design, Synthesis and Biological Activity of Novel Chalcone Derivatives Containing Indole

Design, Synthesis, and Antiviral Activities of 1,5-Benzothiazepine Derivatives Containing Pyridine Moiety.

Synthesis and Antiviral Bioactivity of Novel 2‐substituted Methlthio‐5‐(4‐Amino‐2‐Methylpyrimidin‐5‐yl)‐1,3,4‐Thiadiazole Derivatives

Synthesis, Anti-Tobacco Mosaic Virus and Cucumber Mosaic Virus Activity, and 3D-QSAR Study of Novel 1,4-Pentadien-3-one Derivatives Containing 4-Thioquinazoline Moiety.

Novel Flavonoid Derivatives Containing Benzothiazole As Potential Antiviral Agents: Design, Synthesis, and Biological Evaluation